Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Nachbaur

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Transfusion|July 1, 1995
Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibilityW Nussbaumer, H Schwaighofer, A Gratwohl, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1991
Phenotype and topography of human thymic B cells. An immunohistologic studyF Fend, D Nachbaur, F Oberwasserlechner, et al.
Bone Marrow Transplantation|December 24, 1997
CD34+-selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors. A single-centre experienceD Nachbaur, F M Fink, W Nussbaumer, et al.
Transplantation|December 15, 1995
Nitric oxide formation as predictive parameter for acute graft-versus-host disease after human allogeneic bone marrow transplantationG Weiss, H Schwaighofer, M Herold, et al.
Bone Marrow Transplantation|May 1, 1997
Polychemotherapy combined with G-CSF-mobilized donor buffy coat transfusion for granulocytic sarcoma after allogeneic BMT for AMLD Nachbaur, H C Duba, H Feichtinger, et al.
Journal of Hematotherapy & Stem Cell Research|November 25, 2000
Phenotypic and functional lymphocyte recovery after CD34+-enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantationD Nachbaur, G Kropshofer, A Heitger, et al.
Wiener Klinische Wochenschrift|January 1, 1994
[Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors]D Nachbaur, H Schwaighofer, J Thaler, et al.
Bone Marrow Transplantation|September 28, 2011
Bone marrow may be the preferable graft source in recipients homozygous for HLA-C group 2 ligands for inhibitory killer Ig-like receptorsJ Clausen, B Kircher, J Auberger, et al.
Annals of Hematology|February 1, 1993
Cytokine serum levels during treatment with high-dose recombinant human IL-3 in a patient with severe aplastic anemiaD Nachbaur, A Gratwohl, M Herold, et al.
Annals of Hematology|October 6, 1998
Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessmentM Kopp, H Schweigkofler, B Holzner, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Transfusion|July 1, 1995
Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibilityW Nussbaumer, H Schwaighofer, A Gratwohl, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1991
Phenotype and topography of human thymic B cells. An immunohistologic studyF Fend, D Nachbaur, F Oberwasserlechner, et al.
Bone Marrow Transplantation|December 24, 1997
CD34+-selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors. A single-centre experienceD Nachbaur, F M Fink, W Nussbaumer, et al.
Transplantation|December 15, 1995
Nitric oxide formation as predictive parameter for acute graft-versus-host disease after human allogeneic bone marrow transplantationG Weiss, H Schwaighofer, M Herold, et al.
Bone Marrow Transplantation|May 1, 1997
Polychemotherapy combined with G-CSF-mobilized donor buffy coat transfusion for granulocytic sarcoma after allogeneic BMT for AMLD Nachbaur, H C Duba, H Feichtinger, et al.
Journal of Hematotherapy & Stem Cell Research|November 25, 2000
Phenotypic and functional lymphocyte recovery after CD34+-enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantationD Nachbaur, G Kropshofer, A Heitger, et al.
Wiener Klinische Wochenschrift|January 1, 1994
[Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors]D Nachbaur, H Schwaighofer, J Thaler, et al.
Bone Marrow Transplantation|September 28, 2011
Bone marrow may be the preferable graft source in recipients homozygous for HLA-C group 2 ligands for inhibitory killer Ig-like receptorsJ Clausen, B Kircher, J Auberger, et al.
Annals of Hematology|February 1, 1993
Cytokine serum levels during treatment with high-dose recombinant human IL-3 in a patient with severe aplastic anemiaD Nachbaur, A Gratwohl, M Herold, et al.
Annals of Hematology|October 6, 1998
Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessmentM Kopp, H Schweigkofler, B Holzner, et al.
Pageof 7